StonvexLoading…
StonvexStonvexStonvexCore line items from PDYN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.54M | $5.25M | $3.58M | $2.73M |
Operating Income | $-11.92M | $-32.40M | $-23.09M | $-15.03M |
Net Income | $-12.61M | $10.04M | $11.53M | $15.27M |
EPS (Diluted) | $-0.28 | $0.24 | $0.29 | $0.39 |
Total Assets | $92.55M | $95.71M | $72.93M | $78.31M |
Total Liabilities | $22.64M | $21.04M | $21.08M | $24.48M |
Cash & Equivalents | $17.85M | $18.22M | $27.36M | $20.15M |
Free Cash Flow OCF − CapEx | $-10.27M | $-28.35M | $-19.61M | $-12.94M |
Shares Outstanding | 47.24M | 46.12M | 42.04M | 40.37M |